🔆 SCHEME A DAY | BIO-NIVESH
📍 Why in News?
DBT launched BIO-NIVESH (3 Sept 2026) to connect biotech innovators with private investors and address funding gaps.
🔹 What is BIO-NIVESH?
• Investor–innovator platform (not a fund)
• Organised by BIRAC under DBT
• Covers Health, Agriculture, Environment & Industrial Biotech
💡 Key Focus:
Bridging the “Valley of Death” — gap between lab innovation and commercial success due to high costs, risks and long development cycles.
🚀 Benefits:
✅ Connects startups with investors
✅ Improves biotech investment ecosystem
✅ Supports scalable innovations
📊 India’s Bioeconomy:
• $50 billion (2024)
• Target: $250 billion by 2030
• 6,900+ biotech startups
• 3rd largest biotech hub in Asia-Pacific
🔗 Policy Links:
National Biopharma Mission | BioE3 Policy | RDI Fund | BIRAC
🎯 UPSC Link:
GS-III → Biotechnology | Innovation | Economy
✍️ Mains Angle:
How can BIO-NIVESH help bridge the ‘valley of death’ in India’s biotechnology sector?
#PIBDecoded #UPSC #CurrentAffairs #Biotechnology